Patents Assigned to Therion Biologics
  • Recombinant fowlpox virus and recombination vector
    Patent number: 5093258
    Abstract: Recombinant fowlpox virus (FPV) capable of expressing immunogenic proteins of fowl pathogens are described. The FPV express DNA of the pathogen under the direction of FPV promoters. The recombinant FPV provide live vaccines for poultry and other animals.
    Type: Grant
    Filed: August 26, 1988
    Date of Patent: March 3, 1992
    Assignee: Therion Biologics Corporation
    Inventors: Lawrence K. Cohen, Dennis L. Panicali